WELCOME TO

NOBIS 2026

29 – 30 January 2026
Gothenburg, Sweden

29-30 January 2026 Gothenburg, Sweden

Save the date for the 2nd Nordic Orthopaedic Bone Infection Symposium (NOBIS 2026)

We look forward to welcoming you to the 2nd Nordic Orthopaedic Bone Infection Symposium (NOBIS 2026) on 29-30 January 2026.

The symposium will take place at the Hotel Säröhus by the sea – 20 minutes from Gothenburg, Sweden.

NOBIS wants to unite the Nordic countries by sharing knowledge about managing the multidisciplinary take on bone infections.

We invite all orthopaedic surgeons, infectious disease specialists, and clinical microbiologists for this 2-day event.

See you in Sweden in 2026!

On behalf of the Local Organising Committee
Anders Jönsson, Claes Olsson & Simon Vikström
Department of Orthopaedic Surgery, Sahlgrenska University Hospital, Sweden

ABOUT

NOBIS

The 1st Nordic Orthopaedic Bone Infection Symposium (NOBIS 2024) – took place in Copenhagen in May 2024.

This symposium was established to unite experts from across the Nordic countries, focusing on bone and joint infections. NOBIS provides a platform for orthopaedic surgeons, infection specialists, and clinical microbiologists to exchange knowledge and expertise, with the aim of fostering collaboration across Scandinavia.

NOBIS aims to enhance the collective understanding of the challenges in diagnosing, managing, and treating bone and joint infections. By highlighting the importance of multidisciplinary cooperation, the symposium seeks to promote advances in both surgical and medical strategies for better patient outcomes.

OUR

Obectives

HFUS

Introduction to High Frequency Ultrasonography

HFUS is a recently introduced diagnostic technique, which finds several applicationsin diverse clinical fields. It uses a range of frequencies higher than 20 MHz and provides a high spatial resolution, making this technique suitable for several clinical applications, such as imaging of skin, blood vessels, musculoskeletal anatomy, oral mucosa, and small parts.

Considering the many applications of HFUS in dermatology, we want to highlight its suitability in clinical evaluation of melanocytic lesions and non-proliferative diseases, which includes lichen sclerosus, morphea, sarcoidosis, hidradenitis suppurativa, chronic and acute wounds.

Moreover, HFUS may be useful in the evaluation of micro-vascularity, skin thickness modifications and skin structures modifications in systemic diseases (e.g., diabetes and Sjogren disease).

Latest News